a 44-year-old man with acquired immunodeficiency syndrome ( aids ) and pneumocystis carinii pneumonia ( pcp ) who suffered adverse effects from treatment with trimethoprim-sulfamethoxazole ( tmp-smx ) and was then treated with pentamidine isethionate is described , and approved and investigational drugs used in the management of pcp in the aids patient are discussed .
C0030864
pentamidine isethionate
C1535939
pcp